Tumour invasion and trophoblastic invasion share the same biochemical media
tors: the matrix metalloproteinases (MMPs) and their inhibitors. MMPs are a
family of enzymes capable of digesting the extracellular matrices of the h
ost tissues. Human cytotrophoblastic cells are constitutively invasive and
produce MMPs. Tissue inhibitors of metalloproteinases inhibit cytotrophobla
stic invasion in vitro, indicating that MMPs are causally related to tropho
blast invasion in the endometrium. Ln contrast to tumour invasion of a host
tissue, trophoblastic invasion during implantation and placentation is con
trolled stringently in both space and time. The factors responsible for the
se important regulatory processes are unknown but studies in vitro indicate
that endometrial cytokines and growth factors are possible candidates. Ins
ulin-like growth factor binding protein 1, the major secretory product of t
he decidua, interleukin 1, interleukin 6, leptin and tumour necrosis factor
alpha, all of endometrial origin, are stimulators of MMPs, whereas transfo
rming growth factor beta inhibits the proteolytic activity of cytotrophobla
stic cells. Unfortunately, the ways in which these individual factors inter
act to regulate trophoblast invasion are far from being understood.